Advanced Esophageal Squamous Cell Cancer
4 clinical trials · Condition
◉ Watch Advanced Esophageal Squamous Cell Cancer
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma. (NCT05323890) | Shandong Cancer Hospital and Institute | 2022-04-20 |
| SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer (NCT04797507) | Peking Union Medical College Hospital | 2021-03-01 |
| Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer (NCT04437212) | RenJi Hospital | 2020-07-01 |
| SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer (NCT03732508) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-01 |
Track Advanced Esophageal Squamous Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.